Immunologic effects of interleukin-2 (IL-2) gene therapy in prostate cancer (CaP).

被引：0
作者：
Naitoh, J
Kaboo, R
Tso, CL
Hinkel, A
Stiles, A
Figlin, R
Belldegrun, A
机构：
来源：
JOURNAL OF UROLOGY | 1998年 / 159卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
47
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
[31]   IL-2 AND GENE-THERAPY OF CANCER [J].
BUBENIK, J .
INTERNATIONAL JOURNAL OF ONCOLOGY, 1993, 2 (06) :1049-1052
[32]   Interleukin-2 ((IL-2) gene polymorphism and association with heat tolerance in Nigerian goats [J].
Yakubu, A. ;
Salako, A. E. ;
Donato, M. D. ;
Takeet, M. I. ;
Peters, S. O. ;
Wheto, M. ;
Okpeku, M. ;
Imumorin, I. G. .
SMALL RUMINANT RESEARCH, 2016, 141 :127-134
[33]   INTERLEUKIN-2 (IL-2) UPREGULATES IL-2 RECEPTOR EXPRESSION - EVIDENCE THAT IL-2 AUGMENTS IL-2 RECEPTOR MESSENGER-RNA [J].
DEPPER, J ;
LEONARD, W ;
DROGULA, C ;
KRONKE, M ;
WALDMANN, T ;
GREENE, W .
FEDERATION PROCEEDINGS, 1985, 44 (03) :786-786
[34]   IMMUNE RECONSTITUTION IN PRIMARY IMMUNODEFICIENCIES BY INTERLEUKIN-2 (IL-2) [J].
MAZUMDER, A ;
GUERRA, IC ;
ROSENBLATT, HM ;
SHEARER, WT .
PEDIATRIC RESEARCH, 1985, 19 (04) :A278-A278
[35]   CLONING OF THE BOVINE INTERLEUKIN-2 (IL-2) RECEPTOR CDNA [J].
WEINBERG, A ;
ELLIOTT, J ;
PAETKAU, V ;
BLEACKLEY, C ;
MAGNUSON, N ;
REEVES, R ;
MAGNUSON, J .
FEDERATION PROCEEDINGS, 1987, 46 (03) :770-770
[36]   INTERLEUKIN-2 (IL-2) INDUCES PHOSPHORYLATION OF PLATELET PROTEINS [J].
AIKEN, ML .
FASEB JOURNAL, 1994, 8 (04) :A337-A337
[37]   CARDIOTOXICITY OF HUMAN RECOMBINANT INTERLEUKIN-2 (IL-2) IN RATS [J].
ZHANG, J ;
HERMAN, EH ;
MCCLURE, HM ;
CHADWICK, DP ;
FERRANS, VJ .
FASEB JOURNAL, 1991, 5 (04) :A507-A507
[38]   INTERLEUKIN-2 (IL-2) PRODUCTION IN UREMIC AND DIALYSIS PATIENTS [J].
CHOI, KH ;
KIM, YK ;
HA, SK ;
LEE, HY ;
HAN, DS .
KIDNEY INTERNATIONAL, 1991, 39 (01) :216-216
[39]   INTERLEUKIN-2 (IL-2) ABNORMALITIES IN RHEUMATOID-ARTHRITIS [J].
ANDARY, M ;
COMBE, B ;
KLEIN, B ;
SANY, J ;
CLOT, J .
IMMUNOBIOLOGY, 1986, 173 (2-5) :323-323
[40]   Maintenance interleukin-2 (IL-2) and sargramostim (GM-CSF) following high-dose IL-2 (HD IL-2) therapy for metastatic melanoma [J].
Chu, Melinda Bernabe ;
Fesler, Mark ;
Armbrecht, Eric ;
Fosko, Scott ;
Hsueh, Eddy C. ;
Richart, John M. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345